PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Daily consumption of L. nobilis tea (5g dried leaves in 100ml water) for 10 days significantly decreased plasmatic cortisol concentrations and reduced PSS and STAI scores in healthy volunteers [PMID:36881915].
Daily consumption of L. nobilis tea for 10 days significantly increased the concentration of HDL cholesterol in healthy volunteers [PMID:32213118].
Aqueous extract of L. nobilis (AELN) significantly decreased blood pressure parameters and induced vasorelaxant effects in L-NAME-induced hypertensive rats [PMID:35549860].
Laurus nobilis significantly decreased biochemical parameters (excluding HDL) in oxonic acid-induced hyperuricemic rats [PMID:40292062].
Bay leaves were investigated for impacts on gut microbiota composition and short-chain fatty acids in DSS-induced colitis rat models [PMID:38628202].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 33191495 (2021) — Bay leaf phytodermatitis. · Contact dermatitis
- 2.PMID: 35267385 (2022) — Bay Laurel (Laurus nobilis L.) Essential Oil as a Food Preservative Source: Chemistry, Quality Control, Activity Assessment, and Applications to Olive Industry Products. · Foods (Basel, Switzerland)
- 3.PMID: 35053967 (2022) — Isolation of Laurus nobilis Leaf Polyphenols: A Review on Current Techniques and Future Perspectives. · Foods (Basel, Switzerland)
- 4.PMID: 35174687 (2022) — Effectiveness of cardamom (Elettaria cardamomum) or bay leaf (Laurus nobilis L.) powder in improving the quality of Labneh. · Acta scientiarum polonorum. Technologia alimentaria
- 5.PMID: 35549860 (2023)